Binghui Shen

Last updated

Binghui Shen (born 1961), is an American radiobiologist. He is currently the Chair and Professor of Cancer Genetics and Epigenetics at City of Hope National Medical Center.

He graduated BSc from Department of Biology of Zhejiang University in Hangzhou in 1983. From 1983 to 1986, Shen was an assistant in the Department of Agricultural Sciences at Zhejiang Agricultural University (previous and current Zhejiang University). Shen obtained his PhD from Kansas State University. Shen did his postdoctoral research first in the Department of Molecular Biology and Biochemistry at the University of California, Irvine, then in the Life Sciences Division of Los Alamos National Laboratory, New Mexico. [1]

In 1996, Shen joined the Division of Cell & Tumor Biology at City of Hope National Medical Center. In 2000, he became associate professor in the Division of Molecular Medicine. In 2003, Shen was appointed the Director of the Division of Radiation Biology. He's also the Associated Chair and Professor in the Division of Cancer Biology, and a full member of Cancer Biology Program in the Comprehensive Cancer Center.

Shen was elected to the American Association for the Advancement of Science, the American Society of Radiation Research, and is member of the Radiation Study Section of the National Institutes of Health. Shen was named the United States Department of Defense’s 2002 Breast Cancer Research Program panel. [2]

Related Research Articles

The University of Texas Southwestern Medical Center is a public academic health science center in Dallas, Texas. With approximately 18,800 employees, more than 2,900 full-time faculty, and nearly 4 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and state of Texas.

Jerry McKee Adams, FAA, FRS, FAHMS, FRSV is an Australian-American molecular biologist whose research into the genetics of haemopoietic differentiation and malignancy, led him and his wife, Professor Suzanne Cory, to be the first two scientists to pioneer gene cloning techniques in Australia, and to successfully clone mammalian genes.

Kevin P. Campbell is an Investigator for the Howard Hughes Medical Institute, UI Foundation Distinguished Professor, the Roy J. Carver Chair of Molecular Physiology and Biophysics, and head of the department; he is also professor of neurology and internal medicine at the University of Iowa.

Arthur Dale Riggs was an American geneticist who worked with Genentech to express the first artificial gene in bacteria. His work was critical to the modern biotechnology industry because it was the first use of molecular techniques in commercial production of drugs and enabled the large-scale manufacturing of protein drugs, including insulin. He was also a major factor in the origin of epigenetics.

Rakesh K. Jain is the Andrew Werk Cook Professor of Tumor Biology at Massachusetts General Hospital in the Harvard Medical School and Director of the E.L. Steele Laboratories for Tumor Biology at the Massachusetts General Hospital.

Asen A. Hadjiolov was one of the most distinguished scientists in Bulgaria, and was a member of the Bulgarian Academy of Sciences.

Richard D. Cummings is an American biochemist who is the S. Daniel Abraham Professor of Surgery at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, MA. He also the Chief of the Division of Surgical Sciences within the Department of Surgery. He is the Director of the Harvard Medical School Center for Glycoscience, Director of the National Center for Functional Glycomics, and also founder of the Glycomics Core at BIDMC. As of 2018 Cummings is also the Scientific Director of the Feihi Nutrition Laboratory at BIDMC. Before moving to BIDMC/HMS, Cummings was the William Patterson Timmie Professor and Chair of the Department of Biochemistry at Emory University School of Medicine in Atlanta, Georgia from 2006-2015. At Emory, Cummings was a founder in 2007 of the Emory Glycomics Center.

The School of Biological Sciences is a School within the Faculty Biology, Medicine and Health at The University of Manchester. Biology at University of Manchester and its precursor institutions has gone through a number of reorganizations, the latest of which was the change from a Faculty of Life Sciences to the current School.

Brigid L. M. Hogan FRS is a developmental biologist noted for her contributions to mammalian development, stem cell research and transgenic technology and techniques. She is currently a Professor in the Department of Cell Biology at Duke University, Born in the UK, she became an American citizen in 2000.

<span class="mw-page-title-main">Edison Liu</span>

Edison T. Liu, M.D. is the former president and CEO of The Jackson Laboratory, and the former director of its NCI-designated Cancer Center (2012-2021). As CEO of The Jackson Laboratory, the organization doubled revenue, faculty and personnel, expanded globally from two campuses to six, established 13 endowed chairs, and increased the institutional endowment by five-fold. He is currently a Professor and Honorary Fellow at the institution. Before joining The Jackson Laboratory, he was the founding executive director of the Genome Institute of Singapore (GIS), chairman of the board of the Health Sciences Authority, and president of the Human Genome Organization (HUGO) (2007-2013). As the executive director of the GIS, he brought the institution to international prominence as one of the most productive genomics institutions in the world.

<span class="mw-page-title-main">John E. Niederhuber</span>

John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.

Utpal Banerjee is a Distinguished Professor of the Department of Molecular, Cell and Developmental Biology at UCLA. He obtained his Bachelor of Science degree in Chemistry from St. Stephen's College, Delhi University, India and obtained his Master of Science degree in Physical Chemistry from the Indian Institute of Technology, Kanpur, India. In 1984, he obtained a PhD in Chemistry from the California Institute of Technology where he was also a Postdoctoral Fellow in the laboratory of Seymour Benzer from 1984-1988.

Simon N. Powell is a British cancer researcher and radiation oncologist residing in New York City.

<span class="mw-page-title-main">Lynne E. Maquat</span> American biochemist

Lynne Elizabeth Maquat is an American biochemist and molecular biologist whose research focuses on the cellular mechanisms of human disease. She is an elected member of the American Academy of Arts and Sciences, the National Academy of Sciences and the National Academy of Medicine. She currently holds the J. Lowell Orbison Endowed Chair and is a professor of biochemistry and biophysics, pediatrics and of oncology at the University of Rochester Medical Center. Professor Maquat is also Founding Director of the Center for RNA Biology and Founding Chair of Graduate Women in Science at the University of Rochester.

<span class="mw-page-title-main">Mark A. Lemmon</span> English-born biochemist

Mark Andrew Lemmon an English-born biochemist, is the Alfred Gilman Professor of Pharmacology at Yale University where he also directs the Cancer Biology Institute.

Frank W. Putnam was an American biochemist and university professor.

Liu Xinyuan, or Xin-Yuan Liu, is a Chinese molecular biologist. He is a professor of the Shanghai Institute of Biochemistry and Cell Biology and the founding director of the Xinyuan Institute of Medicine and Biotechnology at Zhejiang Sci-Tech University. His research is focussed on cancer, super interferon therapy, and gene therapy. He is an academician of the Chinese Academy of Sciences, the National Academy of Sciences of Ukraine, and The World Academy of Sciences. He has won more than 30 awards including the Ho Leung Ho Lee Prize.

Charis Eng, M.D., Ph.D., is a Singapore-born physician-scientist and geneticist at the Cleveland Clinic, notable for identifying the PTEN gene. She is the Chairwoman and founding Director of the Genomic Medicine Institute of the Cleveland Clinic, founding Director and attending clinical cancer geneticist of the institute’s clinical component, the Center for Personalized Genetic Healthcare, and Professor and Vice Chairwoman of the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine.

<span class="mw-page-title-main">David Gius</span> American physician-scientist

David R. Gius is an American physician-scientist the Zell Family Scholar Professor, Women's Cancer Research Program director, and Vice Chair of Translational Research at Northwestern University's Feinberg School of Medicine Department of Radiation Oncology and Pharmacology. His research focuses into the mechanistic connection between aging, cellular and/or mitochondrial metabolism, and carcinogenesis focusing on the Sirtuin gene family.

References

  1. 沈炳辉受聘浙大光彪教授
  2. The City of Hope National Medical Center - Biography of Binghui Shen Archived April 26, 2009, at the Wayback Machine